Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
01 1Pharmaceutical Works POLPHARMA
02 1Dr.Reddy's Laboratories Limited
03 1Dr.Reddy's laboratories Limited
04 1Neuland Laboratories Limited
05 1AX Pharmaceutical Corp
06 1Aurobindo Pharma Limited
07 1Glenmark Life Sciences Limited
08 1Hainan Poly Pharm. Co., Ltd.
09 1Hetero Drugs Limited
10 1Jubilant Pharmova Limited
11 1Lonza AG
12 3MSN Life Sciences Private Limited
13 1Pliva Croatia Ltd
14 2Quimica Sintetica S.A.
15 1Raks Pharma Pvt. Limited
16 1ScinoPharm Taiwan Ltd.
17 1Unichem Laboratories Limited, India
18 1Zhejiang Huahai Pharmaceutical Co., Ltd.
01 2APREMILAST
02 17Apremilast
03 1Apremilast Form-B
04 1Apremilast Form-M
01 1Canada
02 2China
03 1Croatia
04 12India
05 1Poland
06 2Spain
07 1Taiwan
08 1U.S.A
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
NDC Package Code : 12658-0581
Start Marketing Date : 2014-03-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-988
Start Marketing Date : 2017-12-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-2030
Start Marketing Date : 2018-11-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-993
Start Marketing Date : 2017-06-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14335-433
Start Marketing Date : 2023-08-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (12kg/12kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49187-0757
Start Marketing Date : 2016-02-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11722-062
Start Marketing Date : 2016-05-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53069-1040
Start Marketing Date : 2014-03-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53069-1050
Start Marketing Date : 2014-03-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47621-306
Start Marketing Date : 2017-06-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Apremilast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apremilast, including repackagers and relabelers. The FDA regulates Apremilast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apremilast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Apremilast manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Apremilast supplier is an individual or a company that provides Apremilast active pharmaceutical ingredient (API) or Apremilast finished formulations upon request. The Apremilast suppliers may include Apremilast API manufacturers, exporters, distributors and traders.
click here to find a list of Apremilast suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Apremilast as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Apremilast API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Apremilast as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Apremilast and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Apremilast NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Apremilast suppliers with NDC on PharmaCompass.
We have 17 companies offering Apremilast
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
